Side-chain halogenated amino dicarboxylic acid derivatives as medicaments for treating cardiovascular diseases
AssigneeBayer Aktiengesellschaft
InventorsMichael Harter, Michael Hahn, Claudia Hirth-Dietrich, Andreas Knorr, Elke Stahl, Johannes-Peter Stasch, Frank Wunder
Life of this patent
Estimating the term…
Abstract
The invention relates to COOH compounds of formula (I), to a method for their production and to the use thereof as medicaments. 1
Claims11
A compound of the general formula (I)
- 31
- where
- R1 represents halogen;
- R2 represents H or halogen;
- R3 represents C3-8-cycloalkyl, C3-8-cycloalkenyl or phenyl, where the phenyl radical may additionally carry a substituent from the group consisting of halogen, C1-6-alkyl, C1-6-alkoxy, CF3;
- and its salts, isomers and hydrates:
A process for preparing compounds of the general formula (I), characterized in that compounds of the formula (II)
- 32
- where
- L represents methyl
- are reacted with a C1-6-alkyl 4-formylbenzoate in an organic solvent, if appropriate with heating and simultaneous or subsequent addition of a reducing agent, to give compounds of the formula (III)
- 33
- where
- L is as defined above and Q represents a C1-6-alkyl radical,
- subsequently—with prior ether cleavage to the free hydroxyl group—reacted with a C1-6-alkyl ω-halovalerate in an organic solvent in the presence of a base with heating to give compounds of the formula (IV)
- 34
- where
- Q is as defined above and Q′ represents a C1-6-alkyl radical,
- then reacted with a compound of the formnula IV-A in an organic solvent in the presence of a base with heating
- 35
- where
- R1, R2 and R3 are as defined above and X represents halogen to give compounds of the formula (V)
- 36
- and the compounds of the formula (V) are then hydrolyzed under alkaline conditions to give the compounds of the formula (I).
A medicament, comprising at least one compound of the general formula (I) as claimed in any of the preceding claims.
The use of compounds of the formula (I) as claimed in any of the preceding claims for preparing a medicament for treating cardiovascular disorders.
The use of compounds of the general formula (I) as claimed in any of the preceding claims for preparing medicaments for treating angina pectoris, ischemias and heart failure.
The use of compounds of the general formula (I) as claimed in any of the preceding claims for preparing medicaments for treating hypertension, thromboembolic disorders, arteriosclerosis and venous diseases.
The use of compounds of the general formula (I) as claimed in any of the preceding claims for preparing medicaments for treating fibrotic disorders.
Dependencies are inferred from the claim text.